Prof. Clare Scott is a Consultant Medical Oncologist at the Peter MacCallum Cancer Centre and the Royal Melbourne and Royal Women’s Hospitals and is Head of the Ovarian and Rare Cancers Laboratory at the Walter and Eliza Hall Institute of Medical Research. She has 20 years’ experience in treating breast and ovarian cancer and in clinical cancer genetics in Familial Cancer Clinics. Prof. Scott has been Principal Investigator for more than ten ovarian cancer clinical trials of targeted therapy leading to high impact publications. She has developed new ovarian cancer pre-clinical models and is using genomics to study targeted drug combinations to combat drug resistance. Prof. Scott has established a rare cancer research program to improve access to targeted treatments for patients diagnosed with a rare cancer. She was awarded the Sir Edward Dunlop Cancer Research Fellowship from Cancer Council Victoria (2012) and a Clinical Research Fellowship from the Victorian Cancer Agency (2017). She leads the COSA Rare Cancer group and is a member of the International Rare Cancer Initiative Board and Co-Chair of the Gynaecologic Cancer Intergroup (GCIG) Rare Tumour Committee.
Pre-clinical models of rare subsets of ovarian cancer: the advantages of purity
Calendar of Events
24 July 2019
Add your event
Submit your event to UNSW events. Only events run by UNSW will be accepted. Once approved your event will appear on both the UNSW and Medicine websites.
If your event has a local focus, submit your event to Medicine events. Only events run by Medicine will be accepted. Your event will only appear on Medicine websites. Do not use this if you have added your event to UNSW events.